BridgeBio Pharma Inc. (BBIO)
34.26
-0.59 (-1.69%)
At close: Apr 15, 2025, 3:59 PM
33.99
-0.78%
After-hours: Apr 15, 2025, 07:41 PM EDT
BridgeBio Pharma Revenue
BridgeBio Pharma reported an annual revenue of $221.9M, reflecting a 2285.27% growth. For the quarter ending December 31, 2024, BridgeBio Pharma generated $5.88M in revenue.
Revenue (ttm)
$221.9M
Revenue Growth
2285.27%
Price / Sales Ratio
23.01
Revenue / Employee
$306.07K
Employees
725
Market Cap
6.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 221.9M | +2285.27% |
| Dec 31, 2023 | 9.3M | -88.02% |
| Dec 31, 2022 | 77.65M | +11.38% |
| Dec 31, 2021 | 69.72M | +745.14% |
| Dec 31, 2020 | 8.25M | n/a |